It is likely that she will be assisted by Joshua Sharfstein, who has been acting commissioner since the departure of Andrew von Eschenbach. AdvaMed's Stephen J. Ubl released the a statement following the confirmation. âEURoeWe applaud Dr. HamburgâEUR(TM)s expressed priorities of fostering innovation and further advancing the safety of medical products and we look forward to working with her to ensure the continued safety and effectiveness of medical technologies,âEUR he said.